CPHI vs IR · rev $4.1M vs P/E 49, rev $7.24B
China Pharma Holdings Inc (CPHI) versus Ingersoll Rand Inc (IR) — a side-by-side from cached financials, not a winner call.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
Ingersoll Rand Inc (IR) is a specialty industrial machinery company listed on US.
Latest reported CPHI revenue for 2025-12-31 was $4.1M. Net income was -$3.2M. Revenue was down 8.5% from 2024-12-31 to 2025-12-31. CPHI currently screens at market cap $29.0M.
Latest reported IR revenue for 2024-12-31 was $7.24B. Net income was $846.3M. Revenue was up 5.2% from 2023-12-31 to 2024-12-31. IR currently screens at market cap $28.27B and trailing P/E 48.8.
CPHI currently screens at market cap $29.0M. IR currently screens at market cap $28.27B and trailing P/E 48.8.
Not investment advice. Open the CPHI and IR stock pages for the full models.
Not investment advice.